Saba has comprehensive experience in bioscience engineering, biotechnology, and life sciences, including multidisciplinary subdomains of molecular diagnostics, microfluidics, and bioassays. She advises on the patent landscape of competitors, freedom to operate, patentability of inventions, prosecution, and opposition actions. She handles cases in English.
27 October, 2023
(Invalid) priority rights – going once, going twice…
EPO has released the highly anticipated decision in referrals G1/22 and G2/22. What was the referral about, what did the Board decide, and what are the practical implications – read on to find out. Case background The two Board of Appeal decisions underlying the referral both relate to the same patent family, albeit T1513/17 is against...